Efficacy of intensive, high-dose anthracycline-based therapy in intermediate- and high-grade non-Hodgkin's lymphomas

Role of cell cycle regulatory molecules in retinoic acid- and vitamin D3-induced differentiation of acute myeloid leukaemia cells.

Cell proliferation·2014

TGFbeta inhibits GM-CSF-induced phosphorylation of ERK and MEK in human myeloid leukaemia cell lines via inhibition of phosphatidylinositol 3-kinase (PI3-k).

Cell proliferation·2009

Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.

Oncogene·2001

An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.

Cancer research·2001

Transforming growth factor: signal transduction pathways, cell cycle mediation, and effects on hematopoiesis.

Journal of hematotherapy & stem cell research·2001

Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.

Biochemical and biophysical research communications·2000

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Seminars in oncology·2026

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

Seminars in oncology·2026

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Seminars in oncology·2026

Dual alexithymia: A relational framework for clinical communication in oncology.

Seminars in oncology·2026

SPIB as a context-specific regulator in cancer: from molecular mechanisms to clinical implications.

Seminars in oncology·2026

The role of fumarate and itaconate in tumor microenvironment.

Seminars in oncology·2026

A scalable outpatient framework for BI-RADS 2-4B breast nodule management: an iodine-DMSO transdermal protocol.

Frontiers in health services·2026

Spontaneous rupture of the urinary bladder and hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a case report.

Journal of surgical case reports·2026

Case Report: Life-threatening neutropenia with absolute neutrophil count of zero after low-dose regional arterial infusion chemotherapy to lung in a patient with advanced triple-negative breast cancer after multiple lines of treatment.

Frontiers in oncology·2026

Nucleolin Alterations and ROS Production Associate With Sensitivity of AML Cells to Venetoclax.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

A Giant in the Neck: Cytomorphology of a Rare Cervical Vertebral Lesion.

Cytopathology : official journal of the British Society for Clinical Cytology·2026

Multiparametric MRI differentiation of ovarian endometriomas and hemorrhagic cysts: Quantitative shading, ADC measurements, and morphological sign analysis.

Acta radiologica (Stockholm, Sweden : 1987)·2026

Related Experiment Videos

Efficacy of intensive, high-dose anthracycline-based therapy in intermediate- and high-grade non-Hodgkin's lymphomas

Related Concept Videos

Role of cell cycle regulatory molecules in retinoic acid- and vitamin D3-induced differentiation of acute myeloid leukaemia cells.

TGFbeta inhibits GM-CSF-induced phosphorylation of ERK and MEK in human myeloid leukaemia cell lines via inhibition of phosphatidylinositol 3-kinase (PI3-k).

Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.

An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.

Transforming growth factor: signal transduction pathways, cell cycle mediation, and effects on hematopoiesis.

Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Dual alexithymia: A relational framework for clinical communication in oncology.

SPIB as a context-specific regulator in cancer: from molecular mechanisms to clinical implications.

The role of fumarate and itaconate in tumor microenvironment.

A scalable outpatient framework for BI-RADS 2-4B breast nodule management: an iodine-DMSO transdermal protocol.

Spontaneous rupture of the urinary bladder and hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a case report.

Case Report: Life-threatening neutropenia with absolute neutrophil count of zero after low-dose regional arterial infusion chemotherapy to lung in a patient with advanced triple-negative breast cancer after multiple lines of treatment.

Nucleolin Alterations and ROS Production Associate With Sensitivity of AML Cells to Venetoclax.

A Giant in the Neck: Cytomorphology of a Rare Cervical Vertebral Lesion.

Multiparametric MRI differentiation of ovarian endometriomas and hemorrhagic cysts: Quantitative shading, ADC measurements, and morphological sign analysis.

Related Experiment Videos

Efficacy of intensive, high-dose anthracycline-based therapy in intermediate- and high-grade non-Hodgkin's lymphomas

Related Concept Videos

Related Articles